Triptans are absent from the World Health Organization list of essential medicines
Triptans are notably missing from the World Health Organization's list of essential medicines, a gap that experts have called to be addressed to improve global access for migraine treatment.
The claim is specific and empirical, satisfying Step 0. Retrieved papers [5] and [8] explicitly confirm that triptans are absent from the WHO Essential Medicines List (EML) and highlight this lack of representation. No papers refute this fact.
Karlsson WK, Ostinelli EG, Zhuang ZA, Kokoti L, Christensen RH, Al-Khazali HM, Deligianni CI, Tomlinson A, Ashina H, Ruiz de la Torre E, Diener HC, Cipriani A, Ashina M. Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis.. 2024. https://doi.org/10.1136/bmj-2024-080107
The authors explicitly state that triptans are absent from the WHO List of Essential Medicines and recommend their inclusion.
See more details
Greer Waldrop, Teddy G. Goetz, Omar K. Siddiqi, Igor J. Koralnik, Hiral Shah, Kiran T. Thakur. The World Health Organization's Essential Diagnostics List. 2019. https://doi.org/10.1212/wnl.0000000000008247
The paper notes the lack of neurologic treatments on the WHO EML, specifically mentioning the absence of commonly used medications for migraine such as triptans.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt